NeueHealth, Inc. (NYSE:NEUE) Short Interest Down 30.3% in February

NeueHealth, Inc. (NYSE:NEUE) was the recipient of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 12,400 shares, a decrease of 30.3% from the January 31st total of 17,800 shares. Based on an average daily volume of 36,500 shares, the short-interest ratio is presently 0.3 days. Currently, 0.5% of the company’s stock are sold short.

Analyst Ratings Changes

Separately, Royal Bank of Canada lowered their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

NeueHealth Stock Performance

NYSE NEUE traded down $0.02 during trading hours on Monday, reaching $7.31. The stock had a trading volume of 10,530 shares, compared to its average volume of 25,022. NeueHealth has a 52-week low of $3.79 and a 52-week high of $11.35. The stock has a fifty day moving average of $7.30 and a 200 day moving average of $5.88. The stock has a market cap of $60.56 million, a P/E ratio of -0.14 and a beta of 0.58.

Insider Activity

In related news, CFO Jay Matushak sold 4,970 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $36,430.10. Following the completion of the transaction, the chief financial officer now directly owns 17,747 shares of the company’s stock, valued at $130,085.51. This trade represents a 21.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO George Lawrence Mikan III sold 16,803 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54. Following the transaction, the chief executive officer now owns 83,029 shares in the company, valued at $347,061.22. The trade was a 16.83 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 58,658 shares of company stock worth $377,034. Insiders own 64.30% of the company’s stock.

Institutional Trading of NeueHealth

Large investors have recently made changes to their positions in the business. Partners Group Holding AG purchased a new position in shares of NeueHealth during the third quarter worth $463,000. Northern Trust Corp raised its stake in shares of NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after buying an additional 13,074 shares during the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of NeueHealth in the 4th quarter valued at about $76,000. 63.88% of the stock is owned by hedge funds and other institutional investors.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.